Structural analysis on the pathologic mutant glucocorticoid receptor ligand-binding domains

Darrell E. Hurt, Shigeru Suzuki, Takafumi Mayama, Evangelia Charmandari, Tomoshige Kino

Research output: Contribution to journalArticle

10 Citations (Scopus)


Glucocorticoid receptor (GR) gene mutations may cause familial or sporadic generalized glucocorticoid resistance syndrome. Most of the missense forms distribute in the ligand-binding domain and impair its ligand-binding activity and formation of the activation function (AF)-2 that binds LXXLL motif-containing coactivators. We performed molecular dynamics simulations to ligandbinding domain of pathologic GR mutants to reveal their structural defects. Several calculated parameters including interaction energy for dexamethasone or the LXXLL peptide indicate that destruction of ligand-binding pocket (LBP) is a primary character. Their LBP defects are driven primarily by loss/reduction of the electrostatic interaction formed by R611 and T739 of the receptor to dexamethasone and a subsequent conformational mismatch, which deacylcortivazol resolves with its large phenylpyrazole moiety and efficiently stimulates transcriptional activity of the mutant receptors with LBP defect. Reduced affinity of the LXXLL peptide to AF-2 is caused mainly by disruption of the electrostatic bonds to the noncore leucine residues of this peptide that determine the peptide’s specificity to GR, as well as by reduced noncovalent interaction against core leucines and subsequent exposure of the AF-2 surface to solvent. The results reveal molecular defects of pathologic mutant receptors and provide important insights to the actions of wild-type GR.

Original languageEnglish
Pages (from-to)173-188
Number of pages16
JournalMolecular Endocrinology
Issue number2
Publication statusPublished - 1 Feb 2016


ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Cite this